Preview: Lululemon and DocuSign Report Earnings on Tuesday

Lululemon stock sits at approximately $157, near its 52-week low and not far above its lowest level since September 2025.

Lululemon Athletica and DocuSign both report quarterly earnings on Tuesday, March 17, and the two companies represent entirely different investment narratives that happen to share a reporting date, with Lululemon facing questions about consumer demand at premium price points and DocuSign navigating a very different challenge of post-pandemic revenue normalisation in a sector where AI is beginning to reshape the competitive landscape it has operated in for years.

Lululemon stock sits at approximately $157, near its 52-week low and not far above its lowest level since September 2025, a position that reflects the combination of a broader consumer spending slowdown affecting premium apparel, management pressure from founder Chip Wilson’s ongoing campaign to install new board members, and a period of slower International expansion than the company’s most optimistic projections had anticipated.

Analysts are forecasting that the company’s quarterly results will show revenue declining approximately 0.96% year over year to around $3.56 billion, a number that would represent a meaningful deceleration from the growth rates Lululemon sustained through its most rapid expansion period and that sits awkwardly against the premium valuation the stock still carries relative to its apparel sector peers.

The backdrop of Iran-driven macro uncertainty complicates the consumer discretionary picture further, because elevated energy prices affect consumer confidence in ways that tend to register most sharply at premium lifestyle brands where purchase decisions can be deferred without significant practical consequences.

DocuSign, by contrast, enters the week as a recovery story rather than a deceleration story, with analysts projecting revenue growth of approximately 6.70% in the quarter to $828 million and earnings per share rising from 86 cents to 95 cents, a modest but consistent upward trajectory for a company whose stock fell from $313 in 2021 to roughly $47 currently.

The DocuSign narrative is one of a pandemic-era winner finding a new equilibrium, with the company’s e-signature platform now a commodity infrastructure layer for Business process automation rather than a differentiated product commanding premium pricing, but one that generates predictable, recurring revenue at scale.

The more interesting forward-looking question for DocuSign is how AI contract analysis tools being built by competitors and integrated directly into the workflows that DocuSign sits inside will affect retention rates over the next two to three years, a threat that management has been addressing through its own AI product additions but that remains an unresolved risk for investors trying to model the company’s long-term competitive moat.

Both companies report after Tuesday’s close, with results typically released within minutes of each other, and the reactions in after-hours trading on Tuesday will give institutional investors the clearest available read on consumer and enterprise software sentiment ahead of Wednesday’s considerably larger catalyst set.